cloudfront

Report Detail

OtherGlobal In-Vitro Colorectal Cancer Screening Tests Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2414290
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 138 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global In-Vitro Colorectal Cancer Screening Tests Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

    1 In-Vitro Colorectal Cancer Screening Tests Market Overview

    • 1.1 Product Overview and Scope of In-Vitro Colorectal Cancer Screening Tests
    • 1.2 Classification of In-Vitro Colorectal Cancer Screening Tests by Types
    • 1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue Comparison by Types (2017-2023)
  • 1.2.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Types in 2017
  • 1.2.3 Biomarker Tests
  • 1.2.4 Fecal Occult Blood Tests
  • 1.2.5 CRC DNA Screening Tests
  • 1.3 Global In-Vitro Colorectal Cancer Screening Tests Market by Application
  • 1.3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size and Market Share Comparison by Applications (2013-2023)
  • 1.3.2 Hospital & Clinics
  • 1.3.3 Ambulatory
  • 1.3.4 Home Care
  • 1.4 Global In-Vitro Colorectal Cancer Screening Tests Market by Regions
  • 1.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size (Million USD) Comparison by Regions (2013-2023)
  • 1.4.1 North America (USA, Canada and Mexico) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2013-2023)
  • 1.4.4 South America (Brazil, Argentina, Colombia) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2013-2023)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In-Vitro Colorectal Cancer Screening Tests Status and Prospect (2013-2023)
  • 1.5 Global Market Size of In-Vitro Colorectal Cancer Screening Tests (2013-2023)
  • 2 Manufacturers Profiles

    • 2.1 Abbott Molecular
    • 2.1.1 Business Overview
  • 2.1.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Abbott Molecular In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Beckman Coulter
  • 2.2.1 Business Overview
  • 2.2.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Alere
  • 2.3.1 Business Overview
  • 2.3.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Alere In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Epigenomics
  • 2.4.1 Business Overview
  • 2.4.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Epigenomics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Eiken Chemical
  • 2.5.1 Business Overview
  • 2.5.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Sysmex
  • 2.6.1 Business Overview
  • 2.6.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Siemens Healthcare
  • 2.7.1 Business Overview
  • 2.7.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Quest Diagnostics
  • 2.8.1 Business Overview
  • 2.8.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Quest Diagnostics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Companion Dx
  • 2.9.1 Business Overview
  • 2.9.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Companion Dx In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Oncocyte
  • 2.10.1 Business Overview
  • 2.10.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Oncocyte In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.11 Merck Millipore
  • 2.11.1 Business Overview
  • 2.11.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.11.2.1 Product A
  • 2.11.2.2 Product B
  • 2.11.3 Merck Millipore In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.12 Immunostics
  • 2.12.1 Business Overview
  • 2.12.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.12.2.1 Product A
  • 2.12.2.2 Product B
  • 2.12.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.13 ExiQon
  • 2.13.1 Business Overview
  • 2.13.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.13.2.1 Product A
  • 2.13.2.2 Product B
  • 2.13.3 ExiQon In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.14 Kyowa Medex
  • 2.14.1 Business Overview
  • 2.14.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.14.2.1 Product A
  • 2.14.2.2 Product B
  • 2.14.3 Kyowa Medex In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.15 Mode Diagnostics
  • 2.15.1 Business Overview
  • 2.15.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.15.2.1 Product A
  • 2.15.2.2 Product B
  • 2.15.3 Mode Diagnostics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.16 Randox Laboratories
  • 2.16.1 Business Overview
  • 2.16.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.16.2.1 Product A
  • 2.16.2.2 Product B
  • 2.16.3 Randox Laboratories In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 2.17 R-Biopharm
  • 2.17.1 Business Overview
  • 2.17.2 In-Vitro Colorectal Cancer Screening Tests Type and Applications
  • 2.17.2.1 Product A
  • 2.17.2.2 Product B
  • 2.17.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global In-Vitro Colorectal Cancer Screening Tests Market Competition, by Players

    • 3.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Share by Players (2013-2018)
    • 3.2 Market Concentration Rate
    • 3.2.1 Top 5 In-Vitro Colorectal Cancer Screening Tests Players Market Share
  • 3.2.2 Top 10 In-Vitro Colorectal Cancer Screening Tests Players Market Share
  • 3.3 Market Competition Trend
  • 4 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Regions

    • 4.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Market Share by Regions
    • 4.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 4.3 Europe In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 4.5 South America In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)

    5 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries

    • 5.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2013-2018)
    • 5.2 USA In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 5.3 Canada In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 5.4 Mexico In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)

    6 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Countries

    • 6.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2013-2018)
    • 6.2 Germany In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 6.3 UK In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 6.4 France In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 6.5 Russia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 6.6 Italy In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)

    7 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Countries

    • 7.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2013-2018)
    • 7.2 China In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 7.3 Japan In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 7.4 Korea In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 7.5 India In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 7.6 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)

    8 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries

    • 8.1 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2013-2018)
    • 8.2 Brazil In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 8.3 Argentina In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 8.4 Colombia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)

    9 Middle East and Africa Revenue In-Vitro Colorectal Cancer Screening Tests by Countries

    • 9.1 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Countries (2013-2018)
    • 9.2 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 9.3 UAE In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 9.4 Egypt In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 9.5 Nigeria In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)
    • 9.6 South Africa In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2013-2018)

    10 Global In-Vitro Colorectal Cancer Screening Tests Market Segment by Type

    • 10.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Market Share by Type (2013-2018)
    • 10.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Type (2018-2023)
    • 10.3 Biomarker Tests Revenue Growth Rate (2013-2023)
    • 10.4 Fecal Occult Blood Tests Revenue Growth Rate (2013-2023)
    • 10.5 CRC DNA Screening Tests Revenue Growth Rate (2013-2023)

    11 Global In-Vitro Colorectal Cancer Screening Tests Market Segment by Application

    • 11.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2013-2018)
    • 11.2 In-Vitro Colorectal Cancer Screening Tests Market Forecast by Application (2018-2023)
    • 11.3 Hospital & Clinics Revenue Growth (2013-2018)
    • 11.4 Ambulatory Revenue Growth (2013-2018)
    • 11.5 Home Care Revenue Growth (2013-2018)

    12 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecast (2018-2023)

    • 12.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecast (2018-2023)
    • 12.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Regions (2018-2023)
    • 12.3 North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2018-2023)
    • 12.4 Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2018-2023)
    • 12.5 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2018-2023)
    • 12.6 South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2018-2023)
    • 12.7 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Forecast (2018-2023)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

      Scope of the Report:

      This report studies the In-Vitro Colorectal Cancer Screening Tests market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In-Vitro Colorectal Cancer Screening Tests market by product type and applications/end industries.

      Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal cancer screening tests market over the forecast period.

      The global In-Vitro Colorectal Cancer Screening Tests market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In-Vitro Colorectal Cancer Screening Tests.

      Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

      Market Segment by Companies, this report covers

      Abbott Molecular

      Beckman Coulter

      Alere

      Epigenomics

      Eiken Chemical

      Sysmex

      Siemens Healthcare

      Quest Diagnostics

      Companion Dx

      Oncocyte

      Merck Millipore

      Immunostics

      ExiQon

      Kyowa Medex

      Mode Diagnostics

      Randox Laboratories

      R-Biopharm

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Biomarker Tests

      Fecal Occult Blood Tests

      CRC DNA Screening Tests

      Market Segment by Applications, can be divided into

      Hospital & Clinics

      Ambulatory

      Home Care




      Summary:
      Get latest Market Research Reports on In-Vitro Colorectal Cancer Screening Tests . Industry analysis & Market Report on In-Vitro Colorectal Cancer Screening Tests is a syndicated market report, published as Global In-Vitro Colorectal Cancer Screening Tests Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of In-Vitro Colorectal Cancer Screening Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report